A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.

Also called NCT07404553

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07404553
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07404553. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-30 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
Condition
Hypercholesterolemia
Intervention (Drug)
SHR-1918 Injection
Intervention (Drug)
SHR-1918 Injection Placebo
Lead sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct07404553
Content hash
de0b0e1428cf34fa42ca42384e5da7c8694976561634ab9c513d0f6740df8317